NovaBay Pharmaceuticals (NYSE:NBY – Get Free Report) and Royalty Pharma (NASDAQ:RPRX – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk. Insider & Institutional Ownership 23.3% of NovaBay Pharmaceuticals […]